ALM Ortho, Inc.

ALM Ortho, Inc. operates in the orthopedic sector, specializing in advanced implant solutions that address complex surgical challenges, particularly in limb restoration and trauma-related conditions. Founded in 2020, ALM Ortho, Inc. is based in Portland, Oregon, US, and focuses on innovative orthopedic solutions.

The company has secured a total of USD 1. 00 mn in funding, with its latest round being a Series A investment co-led by Central Texas Angel Network and Keiretsu Forum, completed on October 25, 2024. The firm has executed one deal to date, reflecting its commitment to advancing orthopedic care. ALM Ortho provides a variety of orthopedic implant solutions aimed at resolving complex surgical issues, specifically in areas such as osseointegration, limb lengthening, total joint arthroplasty revision, and trauma-related orthopedic problems.

Their flagship product, TiGraft Osseointegration, enhances the integration of prosthetic limbs with the skeletal system, improving patient mobility. The company collaborates with orthopedic surgeons to tailor solutions to individual patient needs, distributing primarily to healthcare institutions and surgical centers across the US, while planning for international market expansion. ALM Ortho's revenue model is centered around B2B transactions with healthcare providers and surgical specialists who utilize their orthopedic implant products. The company engages in direct sales partnerships for their products, including the TiGraft Osseointegration solution, with pricing tailored to the complexity of each case.

ALM Ortho also collaborates with distributors to enhance market reach, addressing the growing demand for advanced limb restoration technologies. In October 2024, ALM Ortho raised USD 1. 00 mn in Series A funding, aimed at enhancing product development and expediting the commercialization process of their offerings. The company is focused on designing new products to meet emerging market needs and plans to expand into international markets as demand increases, leveraging the recent funding to support these initiatives.